FDA Clearance Tracker · P220005
CRCDx RAS Mutation Detection Assay Kit
Last checked: Nov 20, 2026Latest source record: Sep 29, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 29, 2023
Approved
Time to decision
527 days
Received Apr 20, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P220005
- Device name
- CRCDx RAS Mutation Detection Assay Kit
- Applicant
- Entrogen, Inc.
- Applicant location
- Woodland Hills, CA
- Received
- Apr 20, 2022
- Decided
- Sep 29, 2023
- Decision
- Approved
Device type
- Device type
- Somatic gene mutation detection system (OWD)
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
Approval for the CRCdx® RAS Mutation Detection Kit. The device is a qualitative real-time PCR in vitro diagnostic test intended for the detection of 35 variants of KRAS and NRAS exon 2, 3, 4 somatic mutations in genomic DNA extracted from formalin-fixed, paraffin-embedded (FFPE) colorectal cancer (CRC) tissue samples. The test is intended as a companion diagnostic (CDx) to aid in the identification of colorectal cancer (mCRC) patients who may benefit from treatment with Vectibix (panitumumab) based on a no mutation detected test result in accordance with the approved therapeutic product labeling.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OWD. The earliest in FDA's data is P110020, decided Aug 17, 2011.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Entrogen, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.